Verhoef LM, den Broeder N, Thurlings, et al. Ultra-low doses of rituximab or retreatment of rheumatoid arthritis: a randomised controlled non-inferiority trial. EULAR 2019; Madrid: Abstract LB0010.
Anti-IL-6-therapie bij refractaire gewrichts- en huidbetrokkenheid SSc
jan 2022 | Sclerodermie